GLEN BURNIE – Biomedical device maker and treatment developer Cyto Pulse Sciences has received ethics committee approval to proceed with a study to investigate the safety and tolerability of its Easy Vax™ system in healthy volunteers. Funded by the National Institutes of Health, the research is another step in the company’s plans to commercialize the DNA vaccine-delivery system.
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1323698127.gif)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1270748889.png)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1286484661.jpg)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1312923369.jpg)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1313587373.gif)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1268857522.jpg)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1270748904.png)
![[Advertisement Image]](http://www.arundelbusinessnews.com/wp-content/uploads/groove-ads/1286484732.jpg)